These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Drug treatment for haematemesis and melaena. Langman MJ Postgrad Med J; 1986; 62 Suppl 2():57-61. PubMed ID: 2890151 [TBL] [Abstract][Full Text] [Related]
7. Management of bleeding peptic ulcer: current status of intravenous proton pump inhibitors. McCarthy DM Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():7-12. PubMed ID: 15588788 [TBL] [Abstract][Full Text] [Related]
8. Our experience with the therapy of bleeding peptic ulcers. Regós J; Sárospataki A; Harasta E; Kökény Z Acta Chir Hung; 1998; 37(3-4):205-10. PubMed ID: 10379373 [TBL] [Abstract][Full Text] [Related]
9. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists. Fusamoto H; Kawano S; Tsuji S; Oshita M; Nagano K; Ohmae A; Sawaoka H; Nagai Y; Kasahara A; Sugimoto T; Kamada T Hepatogastroenterology; 1996; 43(7):169-73. PubMed ID: 8682457 [TBL] [Abstract][Full Text] [Related]
10. [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers]. Evseev MA; Ivakhov GB; Golovin RA Khirurgiia (Mosk); 2009; (3):46-52. PubMed ID: 19391208 [No Abstract] [Full Text] [Related]
12. [Peptic ulcer hemorrhage and acid suppression. More is better?]. Hackelsberger A Leber Magen Darm; 1995 May; 25(3):110-1. PubMed ID: 7609588 [No Abstract] [Full Text] [Related]
13. [Do proton pump inhibitors after endoscopic control of acute ulcer hemorrhage have an advantage over H2 receptor antagonists?]. Prassler R; Hendrich H; Barnert J; Richter G; Fleischmann R; Wienbeck M Z Gastroenterol; 1995 Aug; 33(8):431-4. PubMed ID: 7483734 [TBL] [Abstract][Full Text] [Related]
14. [H2 blockers in the treatment of bleeding gastroduodenal ulcers]. Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821 [No Abstract] [Full Text] [Related]
15. [Conservative treatment of ulcer hemorrhage with histamine H2 antagonists]. Grigor'ev PI; Grinberg AA; Toguzova DA; Iakovenko AV; Lopatina IV Khirurgiia (Mosk); 1997; (5):63-5. PubMed ID: 9297029 [No Abstract] [Full Text] [Related]
16. Pharmacotherapy of bleeding peptic ulcers--is it time to give up the search? Langman MJ Gastroenterology; 1990 Jun; 98(6):1724-6. PubMed ID: 1970969 [No Abstract] [Full Text] [Related]
17. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164 [TBL] [Abstract][Full Text] [Related]
19. Recurrent giant longitudinal duodenal ulcer with massive hemorrhage in a Helicobacter pylori-negative patient. Fujimoto M; Shimizu I; Horie T; Inoue H; Okazaki M; Niki M; Shiraishi T; Fujiwara S; Murata M; Yamamoto K; Iuchi A; Hino A; Ito S J Med Invest; 2001 Aug; 48(3-4):210-5. PubMed ID: 11694961 [TBL] [Abstract][Full Text] [Related]
20. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding? Geus WP Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]